The US critical and growing dependence on China for pharmaceuticals

By Joel Wong

The United States has a critical and growing dependence on China for pharmaceuticals, but the true scale of this reliance is often hidden deep in the supply chain.

While the U.S. imports a relatively moderate amount of finished pills directly from China, it is heavily dependent on China for the chemical building blocks—Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs)—that are required to make those drugs.

The following breakdown details the layers of this dependence based on data from late 2024 and 2025.

The “Hidden” Supply Chain: Ingredients vs. Finished Drugs

The most vital distinction to understand is that while a drug might be stamped “Made in India” or “Made in the USA,” its active chemical components often come from China.

* Active Pharmaceutical Ingredients (APIs): These are the actual medicinal chemicals in a pill (e.g., the ibuprofen itself).

* Estimates suggest China controls 80–90% of the global supply of APIs for antibiotics and other key compounds.

* The India Factor: India is the world’s largest supplier of generic drugs to the U.S., but India imports ~70–80% of its own APIs from China. This means a vast portion of U.S. generics are indirectly dependent on China.

* Key Starting Materials (KSMs): These are the raw chemicals used to create APIs.

* Up to 50% of U.S. generic drugs rely on KSMs produced in China.

* For many drugs, China is the only global source for specific KSMs, creating a “chokepoint” where no alternative supplier exists.

Dependency by Drug Category

The dependence is not uniform; it is dangerously concentrated in specific, high-volume categories of medicine:
Drug Category Estimated Dependence Context & Specifics
Antibiotics >90% The U.S. relies on China for nearly all imports of penicillin, streptomycin, and tetracycline APIs.
Ibuprofen 95% The vast majority of the global supply for this common NSAID originates in China.
Hydrocortisone 90%+ A critical steroid used for treating severe inflammation and adrenal insufficiency.
Acetaminophen 70% The primary active ingredient in Tylenol and various over-the-counter pain relievers.
Vitamins 70–85% China dominates the global production of Vitamins C, B12, B6, and B1.

Recent Strategic Risks (2024–2025 Context)

Recent government reports (such as from the U.S.-China Economic and Security Review Commission) have flagged this dependence as a national security vulnerability.

* Generic Drugs: Generics make up 90% of all U.S. prescriptions. The supply chain for these is heavily exposed to China, unlike branded drugs which often have more diverse or domestic supply chains.

* Contract Research: Major U.S. pharmaceutical companies increasingly rely on Chinese firms (like WuXi AppTec) for research and manufacturing services. Decoupling from these services is estimated to take nearly a decade.

* Export Controls: There is growing concern that China could restrict exports of life-saving medicines or ingredients during geopolitical tensions, effectively “weaponizing” the drug supply chain.

Summary

If you look only at finished drugs entering U.S. ports, China appears to be a minor player (providing roughly 13% by volume). However, if China were to shut off its exports of raw ingredients (APIs and KSMs), the U.S. production of antibiotics, generic painkillers, and common hospital drugs would likely face catastrophic shortages within months.